Funding · Company

Shenandoah Therapeutics Inc.

South San Francisco, CASoftware & Technology

Shenandoah Therapeutics Inc. of South San Francisco, CA has disclosed $21M across 1 Form D offering filed with the SEC on May 15, 2025.

$21M

Total disclosed

Form D offering

2022

Incorporated

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$21M

Form D · May 15, 2025 ↗

Q2 2025

Filing details

HeadquartersSouth San Francisco, CAIndustrySoftware & Technology (Other Technology)Incorporated2022SEC CIK0002068421Offerings on file1

Links

All SEC filings for this company ↗ shenandoahtherapeutics.com ↗ More software & technology raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →